Xin Nian

机构：Kunming Medical University, First Affiliated Hospital of Kunming Medical University · ORCID：0000-0002-4418-533X

发表论文 14 篇 · 总被引 162 次 · h-index 6

代表论文

• Obesity: pathophysiology and therapeutic interventions (2025 · Molecular Biomedicine · 被引 71)
• Correlation between intestinal flora and GLP-1 receptor agonist dulaglutide in type 2 diabetes mellitus treatment—A preliminary longitudinal study (2024 · iScience · 被引 25)
• Berberine as a multi-target therapeutic agent for obesity: from pharmacological mechanisms to clinical evidence (2025 · European journal of medical research · 被引 19)
• GLP-1 receptor agonists modulate blood glucose levels in T2DM by affecting Faecalibacterium prausnitzii abundance in the intestine (2023 · Medicine · 被引 14)
• Relationships of adiponectin to regional adiposity, insulin sensitivity, serum lipids, and inflammatory markers in sedentary and endurance-trained Japanese young women (2023 · Frontiers in Endocrinology · 被引 14)
• Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue (2022 · Frontiers in Endocrinology · 被引 6)